) revealed that it has developed a first of its kind
collaborative framework in Leeds, U.K. to establish a Health
Information Exchange in the city to support the single electronic
health record (EHR) to be used by National Health Service (NHS).
The collaboration agreement involves Leeds and Partners - an
organization responsible for drawing investment to Leeds, as well
as local health and social services providers including general
practitioners and hospitals in Leeds. The collaborative framework
aims to enhance the existing information technology assets in
Leeds with the use of Alere's healthcare platform.
Under the framework, patient data will be securely held by the
NHS but not to be shared by the health and social care partners
in Leeds. The partners will demonstrate the way to transform the
health system with the help of advanced technologies.
ALR will establish a site in Leeds to support this project. The
company would also need other professionals for the project,
mainly in clinical and technology positions in local clinics and
hospitals. If the project succeeds, hundreds of new jobs will be
created in Leeds in the next two years with the adoption of the
Alere reported a 40.5% rise in second quarter 2013 adjusted
earnings per share to 59 cents from 42 cents in the same quarter
of 2012. With this, earnings beat the Zacks Consensus Estimate by
a significant margin of 19 cents.
Net revenues went up 9.1% to $764.0 million in the second quarter
of 2013, exceeding the Zacks Consensus Estimate of $722 million.
Adjusted net revenues rose 9.0% to $764.6 million in the quarter
from $701.6 million for the second quarter of 2012
Currently, Alere carries a Zacks Rank #1 (Strong Buy). Other
medical products stocks such as
Boston Scientific Corp.
) are also worth a look presently. All of them carries a Zacks
Rank #2 (Buy).
ADVAXIS INC (ADXS): Free Stock Analysis
ALERE INC (ALR): Free Stock Analysis Report
BOSTON SCIENTIF (BSX): Free Stock Analysis
DIADEXUS INC (DDXS): Get Free Report
To read this article on Zacks.com click here.